Li Ze-Lei, Ye Shu-Biao, OuYang Li-Yin, Zhang Han, Chen Yu-Shan, He Jia, Chen Qiu-Yan, Qian Chao-Nan, Zhang Xiao-Shi, Cui Jun, Zeng Yi-Xin, Li Jiang
State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Sun Yat-Sen University Cancer Center (SYSUCC) ; Guangzhou, China ; Department of Biotherapy; Sun Yat-Sen University Cancer Center (SYSUCC) ; Guangzhou, China.
State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Sun Yat-Sen University Cancer Center (SYSUCC) ; Guangzhou, China ; Department of Radiotherapy; Sun Yat-Sen University Cancer Center (SYSUCC) ; Guangzhou, China.
Oncoimmunology. 2015 Jul 9;4(11):e1044712. doi: 10.1080/2162402X.2015.1044712. eCollection 2015 Nov.
The expansion of myeloid-derived suppressor cells (MDSCs) is a common feature of cancer, but its biological roles and molecular mechanism remain unclear. Here, we investigated a molecular link between MDSC expansion and tumor cell metastasis in nasopharyngeal carcinoma (NPC). We demonstrated that MDSCs expanded and were positively correlated with the elevated tumor expression and serum IL-6 levels in NPC patients. Importantly, and MDSCs were poor predictors of patient disease-free survival (DFS). Knocking down tumor expression hampered functional TW03-mediated-MDSC cell (T-MDSC) induction with IL-6 blocking. We identified that T-MDSCs promoted NPC cell migration and invasion by triggering the epithelial-mesenchymal transition (EMT) on cell-to-cell contact, and T-MDSCs enhanced tumor experimental lung metastasis . Interestingly, the contact between T-MDSCs and NPC cells enhanced tumor expression, which subsequently activated the / pathway, resulting in EMT of the cancer cells. Blocking transforming growth factor β (TGFβ) or inducible nitric oxide synthase (iNOS) significantly abolished the T-MDSC-induced upregulation of and EMT scores in NPC cells, whereas the administration of TGFβ or L-arginine supplements upregulated expression and EMT scores in NPC cells. These findings reveal that is a key factor mediating the interaction between MDSCs and tumor cells, suggesting that the inhibition of or MDSCs has the potential to suppress NPC metastasis.
髓源性抑制细胞(MDSC)的扩增是癌症的一个常见特征,但其生物学作用和分子机制仍不清楚。在这里,我们研究了鼻咽癌(NPC)中MDSC扩增与肿瘤细胞转移之间的分子联系。我们证明,NPC患者中MDSC扩增,且与肿瘤表达升高和血清IL-6水平呈正相关。重要的是,MDSC是患者无病生存期(DFS)的不良预测指标。敲低肿瘤表达会阻碍功能性TW03介导的MDSC细胞(T-MDSC)在IL-6阻断下的诱导。我们发现,T-MDSC通过在细胞间接触时触发上皮-间质转化(EMT)促进NPC细胞迁移和侵袭,并且T-MDSC增强肿瘤实验性肺转移。有趣的是,T-MDSC与NPC细胞之间的接触增强了肿瘤表达,随后激活了/途径,导致癌细胞发生EMT。阻断转化生长因子β(TGFβ)或诱导型一氧化氮合酶(iNOS)可显著消除T-MDSC诱导的NPC细胞中表达上调和EMT评分,而给予TGFβ或L-精氨酸补充剂可上调NPC细胞中的表达和EMT评分。这些发现揭示了是介导MDSC与肿瘤细胞相互作用的关键因素,表明抑制或MDSC有可能抑制NPC转移。